FY2025 Earnings Estimate for Calumet Issued By HC Wainwright

Calumet, Inc. (NASDAQ:CLMTFree Report) – Research analysts at HC Wainwright increased their FY2025 earnings estimates for shares of Calumet in a research note issued to investors on Monday, November 10th. HC Wainwright analyst A. Dayal now expects that the oil and gas company will earn ($3.45) per share for the year, up from their previous forecast of ($3.89). HC Wainwright has a “Buy” rating and a $33.00 price target on the stock. The consensus estimate for Calumet’s current full-year earnings is ($3.02) per share. HC Wainwright also issued estimates for Calumet’s Q4 2025 earnings at ($0.50) EPS, FY2026 earnings at ($1.22) EPS, FY2027 earnings at $0.23 EPS, FY2028 earnings at $1.35 EPS and FY2029 earnings at $2.49 EPS.

Calumet (NASDAQ:CLMTGet Free Report) last issued its quarterly earnings data on Friday, November 7th. The oil and gas company reported ($0.21) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.09. The business had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.06 billion. The company’s revenue for the quarter was down 2.0% on a year-over-year basis. During the same period in the previous year, the business posted ($1.18) earnings per share.

A number of other equities analysts also recently commented on CLMT. TD Cowen upped their price objective on shares of Calumet from $15.00 to $18.00 and gave the stock a “hold” rating in a research report on Tuesday. Zacks Research upgraded shares of Calumet from a “strong sell” rating to a “hold” rating in a research note on Thursday, November 6th. Weiss Ratings reissued a “sell (e+)” rating on shares of Calumet in a report on Wednesday, October 8th. The Goldman Sachs Group lifted their price objective on Calumet from $15.00 to $20.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. Finally, UBS Group boosted their target price on Calumet from $12.00 to $13.25 and gave the stock a “neutral” rating in a research report on Tuesday, August 12th. Four research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $20.04.

Check Out Our Latest Research Report on Calumet

Calumet Price Performance

Calumet stock opened at $18.93 on Wednesday. The business has a 50 day simple moving average of $18.71 and a 200-day simple moving average of $16.17. Calumet has a 12 month low of $7.68 and a 12 month high of $23.75. The stock has a market capitalization of $1.64 billion, a PE ratio of -3.63 and a beta of 1.09.

Institutional Trading of Calumet

Large investors have recently bought and sold shares of the company. Amalgamated Bank acquired a new position in shares of Calumet during the 2nd quarter worth $37,000. State of Alaska Department of Revenue acquired a new position in Calumet during the third quarter worth about $56,000. University of Texas Texas AM Investment Management Co. lifted its holdings in shares of Calumet by 109.4% in the second quarter. University of Texas Texas AM Investment Management Co. now owns 3,350 shares of the oil and gas company’s stock valued at $53,000 after purchasing an additional 1,750 shares in the last quarter. Ameritas Investment Partners Inc. acquired a new stake in shares of Calumet in the second quarter valued at approximately $111,000. Finally, Bessemer Group Inc. acquired a new stake in shares of Calumet in the third quarter valued at approximately $150,000. Institutional investors and hedge funds own 34.41% of the company’s stock.

Calumet Company Profile

(Get Free Report)

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.

Read More

Earnings History and Estimates for Calumet (NASDAQ:CLMT)

Receive News & Ratings for Calumet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calumet and related companies with MarketBeat.com's FREE daily email newsletter.